SHL is set to present its market-leading auto-injector offerings and expertise in final assembly and packaging services at the Drug Delivery Partnerships (DDP) conference this year.
The three-day event will run from 28-30 January in Palm Beach Gardens, Florida.
Heading into its twenty-third year, the DDP conference is regarded as a prominent event where pharmaceutical companies gather to source new opportunities and stay at the forefront of the industry.
SHL will exhibit its broad range of advanced drug delivery devices at the conference, including the Needle Isolation Technology (NIT庐) that shields users from needle-stick injuries with its pre-installed needle; the Rotaject庐 technology designed to deliver high volumes of drug formulations with consistent force through a patented clock spring; and Molly庐2.25, a high-volume variation of the Molly庐 line.
The Molly庐2.25 is a successor of the ultra-compact Molly庐 auto-injector, owning the same preconfigured technology that offers a faster product development timeline with a larger capacity to accommodate fill volumes up to 2.25ml. This latest addition to the Molly庐 family is a solution for biotech and pharmaceutical companies seeking to commercialise high-volume drug delivery devices in a timely manner.
SHL business development manager Jamie Gould said: 鈥淧articipating in this conference allows us to connect with new and existing partners and to listen to their needs in drug delivery. SHL鈥檚 contract manufacturing facility is located just some miles south of the event location so this is a hometown event for us. We invite current and future customers to visit our site when in town.鈥�
Company experts will be at the booth to talk about SHL鈥檚 unique final packaging services. As market demands increase, SHL has expanded its in-house capabilities in final assembly, labelling and packaging that ensures a streamlined process for combination products from the development stage to the final stage of becoming market-ready.
SHL director of business development Taras Seniuch said: 鈥淰ertical integration is the backbone of SHL鈥檚 business model, which ranges from device design, tooling fabrication, moulding, and now contract manufacturing. SHL鈥檚 advantage lies in our ability to minimise or eliminate the need for our partners to further outsource activities during development through to commercialization of a finished product.鈥�
Visit SHL at Stand 307 to learn more about SHL鈥檚 products and services.